nodes	percent_of_prediction	percent_of_DWPC	metapath
Imiquimod—CYP3A4—Fingolimod—multiple sclerosis	0.0775	0.246	CbGbCtD
Imiquimod—CYP3A4—Methylprednisolone—multiple sclerosis	0.0499	0.158	CbGbCtD
Imiquimod—CYP3A4—Triamcinolone—multiple sclerosis	0.0378	0.12	CbGbCtD
Imiquimod—CYP3A4—Mitoxantrone—multiple sclerosis	0.0364	0.116	CbGbCtD
Imiquimod—CYP3A4—Betamethasone—multiple sclerosis	0.0325	0.103	CbGbCtD
Imiquimod—CYP3A4—Prednisolone—multiple sclerosis	0.032	0.102	CbGbCtD
Imiquimod—CYP3A4—Prednisone—multiple sclerosis	0.0302	0.0959	CbGbCtD
Imiquimod—CYP3A4—Dexamethasone—multiple sclerosis	0.0189	0.0599	CbGbCtD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TYK2—multiple sclerosis	0.00165	0.00619	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—TYK2—multiple sclerosis	0.00162	0.00607	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—SPP1—multiple sclerosis	0.00162	0.00606	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CXCL10—multiple sclerosis	0.00158	0.00593	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—TYK2—multiple sclerosis	0.00156	0.00586	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—C4A—multiple sclerosis	0.00153	0.00574	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—P2RX7—multiple sclerosis	0.00147	0.0055	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TLR4—multiple sclerosis	0.00144	0.00541	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—TLR4—multiple sclerosis	0.00143	0.00535	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TLR4—multiple sclerosis	0.0014	0.00525	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CD86—multiple sclerosis	0.00138	0.00519	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CCL5—multiple sclerosis	0.00136	0.0051	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—CD80—multiple sclerosis	0.00133	0.00499	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00132	0.00497	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00132	0.00497	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—CD80—multiple sclerosis	0.00129	0.00485	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—SPP1—multiple sclerosis	0.00126	0.00473	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TYK2—multiple sclerosis	0.00125	0.00469	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—TYK2—multiple sclerosis	0.00123	0.0046	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL1B—multiple sclerosis	0.0012	0.00451	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—TYK2—multiple sclerosis	0.00119	0.00444	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—C4A—multiple sclerosis	0.00116	0.00435	CbGpPWpGaD
Imiquimod—TLR8—Immune System—P2RX7—multiple sclerosis	0.00113	0.00423	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—TYK2—multiple sclerosis	0.00111	0.00417	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TLR4—multiple sclerosis	0.00109	0.0041	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—TLR4—multiple sclerosis	0.00108	0.00405	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—NOD1—multiple sclerosis	0.00107	0.00402	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK1—multiple sclerosis	0.00105	0.00394	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD226—multiple sclerosis	0.00105	0.00393	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—MALT1—multiple sclerosis	0.00103	0.00388	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—MAPK1—multiple sclerosis	0.00103	0.00387	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.00102	0.00383	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.00102	0.00383	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-DRB4—multiple sclerosis	0.00102	0.00381	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—CD80—multiple sclerosis	0.00101	0.00378	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—MAPK1—multiple sclerosis	0.000996	0.00373	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IFIH1—multiple sclerosis	0.000973	0.00365	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CIITA—multiple sclerosis	0.00096	0.0036	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL1B—multiple sclerosis	0.000939	0.00352	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—MAPK1—multiple sclerosis	0.000917	0.00344	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL1B—multiple sclerosis	0.000912	0.00342	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TNFAIP3—multiple sclerosis	0.000911	0.00341	CbGpPWpGaD
Imiquimod—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	0.000905	0.00339	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL7—multiple sclerosis	0.000892	0.00334	CbGpPWpGaD
Imiquimod—TLR8—Immune System—C4A—multiple sclerosis	0.000892	0.00334	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—TNF—multiple sclerosis	0.000873	0.00327	CbGpPWpGaD
Imiquimod—TLR7—Immune System—P2RX7—multiple sclerosis	0.000855	0.00321	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PDCD1—multiple sclerosis	0.000855	0.00321	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—TYK2—multiple sclerosis	0.000842	0.00316	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000841	0.00315	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000841	0.00315	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL7R—multiple sclerosis	0.000839	0.00314	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.00083	0.00311	CbGpPWpGaD
Imiquimod—CYP1A2—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.00083	0.00311	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CD28—multiple sclerosis	0.000819	0.00307	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—NOD1—multiple sclerosis	0.000812	0.00304	CbGpPWpGaD
Imiquimod—TLR8—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—multiple sclerosis	0.000807	0.00303	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CCR2—multiple sclerosis	0.000805	0.00302	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—MAPK1—multiple sclerosis	0.000796	0.00298	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD226—multiple sclerosis	0.000795	0.00298	CbGpPWpGaD
Imiquimod—TLR8—MyD88 dependent cascade initiated on endosome—IL6—multiple sclerosis	0.000793	0.00297	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—MALT1—multiple sclerosis	0.000784	0.00294	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—MAPK1—multiple sclerosis	0.000782	0.00293	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HLA-DRB4—multiple sclerosis	0.00077	0.00289	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CBLB—multiple sclerosis	0.00077	0.00289	CbGpPWpGaD
Imiquimod—TLR8—Toll Like Receptor 9 (TLR9) Cascade—IL6—multiple sclerosis	0.000765	0.00287	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—MAPK1—multiple sclerosis	0.000755	0.00283	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—IFNB1—multiple sclerosis	0.000743	0.00278	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IFIH1—multiple sclerosis	0.000737	0.00276	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CIITA—multiple sclerosis	0.000727	0.00273	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12A—multiple sclerosis	0.000721	0.0027	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—MAPK1—multiple sclerosis	0.000716	0.00268	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL1B—multiple sclerosis	0.000712	0.00267	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—MAPK1—multiple sclerosis	0.000708	0.00265	CbGpPWpGaD
Imiquimod—TLR8—Toll-like Receptor Signaling Pathway—IL6—multiple sclerosis	0.000704	0.00264	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—MAPK1—multiple sclerosis	0.000695	0.0026	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TNFAIP3—multiple sclerosis	0.00069	0.00259	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MX1—multiple sclerosis	0.000684	0.00256	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000682	0.00256	CbGpPWpGaD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000682	0.00256	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—TNF—multiple sclerosis	0.000681	0.00255	CbGpPWpGaD
Imiquimod—TLR7—Immune System—C4A—multiple sclerosis	0.000676	0.00253	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL7—multiple sclerosis	0.000676	0.00253	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-DRA—multiple sclerosis	0.000662	0.00248	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—TNF—multiple sclerosis	0.000662	0.00248	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	0.000649	0.00243	CbGpPWpGaD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	0.000649	0.00243	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PDCD1—multiple sclerosis	0.000648	0.00243	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	0.000641	0.0024	CbGpPWpGaD
Imiquimod—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	0.000641	0.0024	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL7R—multiple sclerosis	0.000636	0.00238	CbGpPWpGaD
Imiquimod—TLR8—Immune System—NOD1—multiple sclerosis	0.000624	0.00234	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CD28—multiple sclerosis	0.000621	0.00233	CbGpPWpGaD
Imiquimod—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—multiple sclerosis	0.000612	0.00229	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CCR2—multiple sclerosis	0.00061	0.00229	CbGpPWpGaD
Imiquimod—TLR8—Immune System—MALT1—multiple sclerosis	0.000603	0.00226	CbGpPWpGaD
Imiquimod—TLR7—MyD88 dependent cascade initiated on endosome—IL6—multiple sclerosis	0.000601	0.00225	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IRF5—multiple sclerosis	0.000593	0.00222	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CD86—multiple sclerosis	0.000585	0.00219	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CBLB—multiple sclerosis	0.000584	0.00219	CbGpPWpGaD
Imiquimod—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	0.000582	0.00218	CbGpPWpGaD
Imiquimod—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—multiple sclerosis	0.00058	0.00217	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IRF8—multiple sclerosis	0.000567	0.00212	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-G—multiple sclerosis	0.000567	0.00212	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IFIH1—multiple sclerosis	0.000567	0.00212	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IFNB1—multiple sclerosis	0.000563	0.00211	CbGpPWpGaD
Imiquimod—TLR8—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	0.00055	0.00206	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—HLA-B—multiple sclerosis	0.000545	0.00204	CbGpPWpGaD
Imiquimod—TLR8—Toll-Like Receptors Cascades—IL6—multiple sclerosis	0.000544	0.00204	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—MAPK1—multiple sclerosis	0.000542	0.00203	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—MAPK1—multiple sclerosis	0.000536	0.00201	CbGpPWpGaD
Imiquimod—TLR7—Toll-like Receptor Signaling Pathway—IL6—multiple sclerosis	0.000534	0.002	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TNFAIP3—multiple sclerosis	0.000531	0.00199	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	0.000526	0.00197	CbGpPWpGaD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	0.000526	0.00197	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MX1—multiple sclerosis	0.000518	0.00194	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—TNF—multiple sclerosis	0.000516	0.00194	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HLA-DRA—multiple sclerosis	0.000501	0.00188	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD28—multiple sclerosis	0.000477	0.00179	CbGpPWpGaD
Imiquimod—TLR7—Immune System—NOD1—multiple sclerosis	0.000473	0.00177	CbGpPWpGaD
Imiquimod—TLR8—Immune System—PTPRC—multiple sclerosis	0.000469	0.00176	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CCR2—multiple sclerosis	0.000469	0.00176	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TLR4—multiple sclerosis	0.000462	0.00173	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MALT1—multiple sclerosis	0.000457	0.00171	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-DPB1—multiple sclerosis	0.000453	0.0017	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—multiple sclerosis	0.000453	0.0017	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IRF5—multiple sclerosis	0.000449	0.00168	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CD86—multiple sclerosis	0.000443	0.00166	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD40—multiple sclerosis	0.000436	0.00163	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ITGA4—multiple sclerosis	0.000436	0.00163	CbGpPWpGaD
Imiquimod—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000433	0.00162	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IFNB1—multiple sclerosis	0.000433	0.00162	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IRF8—multiple sclerosis	0.000429	0.00161	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IFIH1—multiple sclerosis	0.000429	0.00161	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HLA-G—multiple sclerosis	0.000429	0.00161	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CTLA4—multiple sclerosis	0.000429	0.00161	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CD80—multiple sclerosis	0.000427	0.0016	CbGpPWpGaD
Imiquimod—TLR7—Regulation of toll-like receptor signaling pathway—IL6—multiple sclerosis	0.000417	0.00156	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—HLA-B—multiple sclerosis	0.000413	0.00155	CbGpPWpGaD
Imiquimod—TLR7—Toll-Like Receptors Cascades—IL6—multiple sclerosis	0.000412	0.00154	CbGpPWpGaD
Imiquimod—TLR7—Immune System—TNFAIP3—multiple sclerosis	0.000402	0.00151	CbGpPWpGaD
Imiquimod—CYP1A2—Estrogen Receptor Pathway—STAT3—multiple sclerosis	0.0004	0.0015	CbGpPWpGaD
Imiquimod—CYP1A2—Melatonin metabolism and effects—APOE—multiple sclerosis	0.000394	0.00148	CbGpPWpGaD
Imiquimod—TLR8—Immune System—VCAM1—multiple sclerosis	0.000379	0.00142	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-DQA1—multiple sclerosis	0.000378	0.00142	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP27B1—multiple sclerosis	0.000362	0.00136	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—CYP24A1—multiple sclerosis	0.000362	0.00136	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD28—multiple sclerosis	0.000362	0.00136	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—TYK2—multiple sclerosis	0.00036	0.00135	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000357	0.00134	CbGpPWpGaD
Imiquimod—CYP1A2—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000357	0.00134	CbGpPWpGaD
Imiquimod—TLR7—Immune System—PTPRC—multiple sclerosis	0.000355	0.00133	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CCR2—multiple sclerosis	0.000355	0.00133	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-DQB1—multiple sclerosis	0.000354	0.00133	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TLR4—multiple sclerosis	0.00035	0.00131	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HLA-DPB1—multiple sclerosis	0.000343	0.00129	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD86—multiple sclerosis	0.000341	0.00128	CbGpPWpGaD
Imiquimod—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	0.000335	0.00125	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD40LG—multiple sclerosis	0.000334	0.00125	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CD40—multiple sclerosis	0.00033	0.00124	CbGpPWpGaD
Imiquimod—TLR7—Immune System—ITGA4—multiple sclerosis	0.00033	0.00124	CbGpPWpGaD
Imiquimod—TLR8—Immune System—CD8A—multiple sclerosis	0.00033	0.00124	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IFNB1—multiple sclerosis	0.000328	0.00123	CbGpPWpGaD
Imiquimod—TLR8—Innate Immune System—CD4—multiple sclerosis	0.000326	0.00122	CbGpPWpGaD
Imiquimod—TLR7—Immune System—CTLA4—multiple sclerosis	0.000325	0.00122	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—CD80—multiple sclerosis	0.000323	0.00121	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-B—multiple sclerosis	0.000318	0.00119	CbGpPWpGaD
Imiquimod—TLR8—Immune System—IL2RA—multiple sclerosis	0.000298	0.00112	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-A—multiple sclerosis	0.000294	0.0011	CbGpPWpGaD
Imiquimod—TLR7—Immune System—VCAM1—multiple sclerosis	0.000287	0.00108	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HLA-DQA1—multiple sclerosis	0.000287	0.00107	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	0.00028	0.00105	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	0.00028	0.00105	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	0.000276	0.00103	CbGpPWpGaD
Imiquimod—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	0.000276	0.00103	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—TYK2—multiple sclerosis	0.000273	0.00102	CbGpPWpGaD
Imiquimod—TLR8—Immune System—TLR4—multiple sclerosis	0.000269	0.00101	CbGpPWpGaD
Imiquimod—TLR8—Immune System—HLA-DRB1—multiple sclerosis	0.000269	0.00101	CbGpPWpGaD
Imiquimod—TLR7—Immune System—HLA-DQB1—multiple sclerosis	0.000268	0.001	CbGpPWpGaD
Imiquimod—Conjunctivitis—Methotrexate—multiple sclerosis	0.000258	0.000618	CcSEcCtD
Imiquimod—TLR7—Immune System—CD86—multiple sclerosis	0.000258	0.000967	CbGpPWpGaD
Imiquimod—TLR8—Immune System—ICAM1—multiple sclerosis	0.000258	0.000967	CbGpPWpGaD
Imiquimod—Immune system disorder—Prednisone—multiple sclerosis	0.000258	0.000617	CcSEcCtD
Imiquimod—Malaise—Betamethasone—multiple sclerosis	0.000257	0.000616	CcSEcCtD
Imiquimod—Malaise—Dexamethasone—multiple sclerosis	0.000257	0.000616	CcSEcCtD
Imiquimod—Oedema—Triamcinolone—multiple sclerosis	0.000257	0.000614	CcSEcCtD
Imiquimod—Syncope—Betamethasone—multiple sclerosis	0.000256	0.000612	CcSEcCtD
Imiquimod—Syncope—Dexamethasone—multiple sclerosis	0.000256	0.000612	CcSEcCtD
Imiquimod—Arrhythmia—Prednisone—multiple sclerosis	0.000255	0.00061	CcSEcCtD
Imiquimod—Infection—Triamcinolone—multiple sclerosis	0.000255	0.00061	CcSEcCtD
Imiquimod—Infection—Methylprednisolone—multiple sclerosis	0.000254	0.000609	CcSEcCtD
Imiquimod—TLR7—Immune System—CD40LG—multiple sclerosis	0.000253	0.000949	CbGpPWpGaD
Imiquimod—Shock—Triamcinolone—multiple sclerosis	0.000252	0.000604	CcSEcCtD
Imiquimod—Insomnia—Prednisolone—multiple sclerosis	0.000252	0.000604	CcSEcCtD
Imiquimod—Alopecia—Prednisone—multiple sclerosis	0.000252	0.000604	CcSEcCtD
Imiquimod—Shock—Methylprednisolone—multiple sclerosis	0.000252	0.000603	CcSEcCtD
Imiquimod—Hepatobiliary disease—Methotrexate—multiple sclerosis	0.000251	0.000601	CcSEcCtD
Imiquimod—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000251	0.000601	CcSEcCtD
Imiquimod—Loss of consciousness—Betamethasone—multiple sclerosis	0.000251	0.0006	CcSEcCtD
Imiquimod—Loss of consciousness—Dexamethasone—multiple sclerosis	0.000251	0.0006	CcSEcCtD
Imiquimod—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000251	0.0006	CcSEcCtD
Imiquimod—Paraesthesia—Prednisolone—multiple sclerosis	0.000251	0.0006	CcSEcCtD
Imiquimod—Tachycardia—Triamcinolone—multiple sclerosis	0.00025	0.000599	CcSEcCtD
Imiquimod—TLR7—Immune System—CD8A—multiple sclerosis	0.00025	0.000938	CbGpPWpGaD
Imiquimod—Mental disorder—Prednisone—multiple sclerosis	0.00025	0.000598	CcSEcCtD
Imiquimod—Nausea—Azathioprine—multiple sclerosis	0.00025	0.000598	CcSEcCtD
Imiquimod—Tachycardia—Methylprednisolone—multiple sclerosis	0.00025	0.000598	CcSEcCtD
Imiquimod—Skin disorder—Methylprednisolone—multiple sclerosis	0.000249	0.000595	CcSEcCtD
Imiquimod—Erythema—Prednisone—multiple sclerosis	0.000248	0.000595	CcSEcCtD
Imiquimod—Malnutrition—Prednisone—multiple sclerosis	0.000248	0.000595	CcSEcCtD
Imiquimod—TLR8—Immune System—CD80—multiple sclerosis	0.000248	0.000931	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000248	0.000594	CcSEcCtD
Imiquimod—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000248	0.000592	CcSEcCtD
Imiquimod—Convulsion—Dexamethasone—multiple sclerosis	0.000247	0.000592	CcSEcCtD
Imiquimod—Convulsion—Betamethasone—multiple sclerosis	0.000247	0.000592	CcSEcCtD
Imiquimod—TLR7—Innate Immune System—CD4—multiple sclerosis	0.000247	0.000925	CbGpPWpGaD
Imiquimod—Hypertension—Betamethasone—multiple sclerosis	0.000246	0.000589	CcSEcCtD
Imiquimod—Hypertension—Dexamethasone—multiple sclerosis	0.000246	0.000589	CcSEcCtD
Imiquimod—Asthenia—Mitoxantrone—multiple sclerosis	0.000244	0.000584	CcSEcCtD
Imiquimod—Myalgia—Betamethasone—multiple sclerosis	0.000243	0.000581	CcSEcCtD
Imiquimod—Myalgia—Dexamethasone—multiple sclerosis	0.000243	0.000581	CcSEcCtD
Imiquimod—Anxiety—Dexamethasone—multiple sclerosis	0.000242	0.000579	CcSEcCtD
Imiquimod—Anxiety—Betamethasone—multiple sclerosis	0.000242	0.000579	CcSEcCtD
Imiquimod—TLR7—Immune System—HLA-B—multiple sclerosis	0.000241	0.000902	CbGpPWpGaD
Imiquimod—Discomfort—Betamethasone—multiple sclerosis	0.00024	0.000574	CcSEcCtD
Imiquimod—Discomfort—Dexamethasone—multiple sclerosis	0.00024	0.000574	CcSEcCtD
Imiquimod—Haemoglobin—Methotrexate—multiple sclerosis	0.00024	0.000574	CcSEcCtD
Imiquimod—Pain—Prednisolone—multiple sclerosis	0.000239	0.000571	CcSEcCtD
Imiquimod—Haemorrhage—Methotrexate—multiple sclerosis	0.000239	0.000571	CcSEcCtD
Imiquimod—Pharyngitis—Methotrexate—multiple sclerosis	0.000237	0.000567	CcSEcCtD
Imiquimod—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000236	0.000564	CcSEcCtD
Imiquimod—Urethral disorder—Methotrexate—multiple sclerosis	0.000234	0.00056	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000234	0.000559	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000233	0.000558	CcSEcCtD
Imiquimod—Oedema—Dexamethasone—multiple sclerosis	0.000233	0.000557	CcSEcCtD
Imiquimod—Oedema—Betamethasone—multiple sclerosis	0.000233	0.000557	CcSEcCtD
Imiquimod—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000233	0.000557	CcSEcCtD
Imiquimod—Insomnia—Triamcinolone—multiple sclerosis	0.000232	0.000555	CcSEcCtD
Imiquimod—Insomnia—Methylprednisolone—multiple sclerosis	0.000232	0.000554	CcSEcCtD
Imiquimod—Infection—Betamethasone—multiple sclerosis	0.000231	0.000554	CcSEcCtD
Imiquimod—Infection—Dexamethasone—multiple sclerosis	0.000231	0.000554	CcSEcCtD
Imiquimod—Ill-defined disorder—Prednisone—multiple sclerosis	0.000231	0.000552	CcSEcCtD
Imiquimod—Paraesthesia—Triamcinolone—multiple sclerosis	0.00023	0.000551	CcSEcCtD
Imiquimod—Feeling abnormal—Prednisolone—multiple sclerosis	0.00023	0.00055	CcSEcCtD
Imiquimod—Paraesthesia—Methylprednisolone—multiple sclerosis	0.00023	0.00055	CcSEcCtD
Imiquimod—Visual impairment—Methotrexate—multiple sclerosis	0.00023	0.00055	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—MAPK1—multiple sclerosis	0.000229	0.000859	CbGpPWpGaD
Imiquimod—Shock—Dexamethasone—multiple sclerosis	0.000229	0.000548	CcSEcCtD
Imiquimod—Shock—Betamethasone—multiple sclerosis	0.000229	0.000548	CcSEcCtD
Imiquimod—Dyspnoea—Triamcinolone—multiple sclerosis	0.000229	0.000547	CcSEcCtD
Imiquimod—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000228	0.000546	CcSEcCtD
Imiquimod—Nervous system disorder—Betamethasone—multiple sclerosis	0.000228	0.000546	CcSEcCtD
Imiquimod—Agitation—Prednisone—multiple sclerosis	0.000228	0.000546	CcSEcCtD
Imiquimod—Tachycardia—Betamethasone—multiple sclerosis	0.000227	0.000544	CcSEcCtD
Imiquimod—Tachycardia—Dexamethasone—multiple sclerosis	0.000227	0.000544	CcSEcCtD
Imiquimod—Angioedema—Prednisone—multiple sclerosis	0.000227	0.000543	CcSEcCtD
Imiquimod—Dyspepsia—Triamcinolone—multiple sclerosis	0.000226	0.000541	CcSEcCtD
Imiquimod—TLR7—Immune System—IL2RA—multiple sclerosis	0.000226	0.000845	CbGpPWpGaD
Imiquimod—Erythema multiforme—Methotrexate—multiple sclerosis	0.000226	0.00054	CcSEcCtD
Imiquimod—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000225	0.000539	CcSEcCtD
Imiquimod—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000225	0.000539	CcSEcCtD
Imiquimod—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000225	0.000539	CcSEcCtD
Imiquimod—Malaise—Prednisone—multiple sclerosis	0.000224	0.000536	CcSEcCtD
Imiquimod—TLR7—Immune System—HLA-A—multiple sclerosis	0.000223	0.000836	CbGpPWpGaD
Imiquimod—Eye disorder—Methotrexate—multiple sclerosis	0.000223	0.000533	CcSEcCtD
Imiquimod—Syncope—Prednisone—multiple sclerosis	0.000223	0.000533	CcSEcCtD
Imiquimod—Tinnitus—Methotrexate—multiple sclerosis	0.000222	0.000532	CcSEcCtD
Imiquimod—Anorexia—Dexamethasone—multiple sclerosis	0.000222	0.000531	CcSEcCtD
Imiquimod—Anorexia—Betamethasone—multiple sclerosis	0.000222	0.000531	CcSEcCtD
Imiquimod—Urticaria—Prednisolone—multiple sclerosis	0.000222	0.00053	CcSEcCtD
Imiquimod—Fatigue—Triamcinolone—multiple sclerosis	0.000221	0.000529	CcSEcCtD
Imiquimod—Fatigue—Methylprednisolone—multiple sclerosis	0.000221	0.000528	CcSEcCtD
Imiquimod—Pain—Triamcinolone—multiple sclerosis	0.000219	0.000525	CcSEcCtD
Imiquimod—Loss of consciousness—Prednisone—multiple sclerosis	0.000218	0.000523	CcSEcCtD
Imiquimod—Angiopathy—Methotrexate—multiple sclerosis	0.000216	0.000518	CcSEcCtD
Imiquimod—Vomiting—Mitoxantrone—multiple sclerosis	0.000216	0.000518	CcSEcCtD
Imiquimod—Immune system disorder—Methotrexate—multiple sclerosis	0.000215	0.000516	CcSEcCtD
Imiquimod—Convulsion—Prednisone—multiple sclerosis	0.000215	0.000515	CcSEcCtD
Imiquimod—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000215	0.000514	CcSEcCtD
Imiquimod—Hypertension—Prednisone—multiple sclerosis	0.000215	0.000513	CcSEcCtD
Imiquimod—Rash—Mitoxantrone—multiple sclerosis	0.000214	0.000513	CcSEcCtD
Imiquimod—Dermatitis—Mitoxantrone—multiple sclerosis	0.000214	0.000513	CcSEcCtD
Imiquimod—Chills—Methotrexate—multiple sclerosis	0.000214	0.000512	CcSEcCtD
Imiquimod—Headache—Mitoxantrone—multiple sclerosis	0.000213	0.00051	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000212	0.000508	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000212	0.000508	CcSEcCtD
Imiquimod—Myalgia—Prednisone—multiple sclerosis	0.000212	0.000506	CcSEcCtD
Imiquimod—Arthralgia—Prednisone—multiple sclerosis	0.000212	0.000506	CcSEcCtD
Imiquimod—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000211	0.000506	CcSEcCtD
Imiquimod—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000211	0.000505	CcSEcCtD
Imiquimod—Anxiety—Prednisone—multiple sclerosis	0.000211	0.000504	CcSEcCtD
Imiquimod—Alopecia—Methotrexate—multiple sclerosis	0.000211	0.000504	CcSEcCtD
Imiquimod—Insomnia—Dexamethasone—multiple sclerosis	0.000211	0.000504	CcSEcCtD
Imiquimod—Insomnia—Betamethasone—multiple sclerosis	0.000211	0.000504	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.00021	0.000503	CcSEcCtD
Imiquimod—TLR8—Immune System—TYK2—multiple sclerosis	0.00021	0.000786	CbGpPWpGaD
Imiquimod—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000209	0.000501	CcSEcCtD
Imiquimod—Paraesthesia—Dexamethasone—multiple sclerosis	0.000209	0.0005	CcSEcCtD
Imiquimod—Paraesthesia—Betamethasone—multiple sclerosis	0.000209	0.0005	CcSEcCtD
Imiquimod—Discomfort—Prednisone—multiple sclerosis	0.000209	0.0005	CcSEcCtD
Imiquimod—Mental disorder—Methotrexate—multiple sclerosis	0.000209	0.0005	CcSEcCtD
Imiquimod—Erythema—Methotrexate—multiple sclerosis	0.000208	0.000497	CcSEcCtD
Imiquimod—Malnutrition—Methotrexate—multiple sclerosis	0.000208	0.000497	CcSEcCtD
Imiquimod—Hypersensitivity—Prednisolone—multiple sclerosis	0.000206	0.000492	CcSEcCtD
Imiquimod—Dyspepsia—Dexamethasone—multiple sclerosis	0.000205	0.00049	CcSEcCtD
Imiquimod—Dyspepsia—Betamethasone—multiple sclerosis	0.000205	0.00049	CcSEcCtD
Imiquimod—TLR7—Immune System—TLR4—multiple sclerosis	0.000204	0.000765	CbGpPWpGaD
Imiquimod—Urticaria—Triamcinolone—multiple sclerosis	0.000204	0.000488	CcSEcCtD
Imiquimod—TLR7—Immune System—HLA-DRB1—multiple sclerosis	0.000204	0.000764	CbGpPWpGaD
Imiquimod—Urticaria—Methylprednisolone—multiple sclerosis	0.000203	0.000487	CcSEcCtD
Imiquimod—Body temperature increased—Triamcinolone—multiple sclerosis	0.000203	0.000485	CcSEcCtD
Imiquimod—Oedema—Prednisone—multiple sclerosis	0.000203	0.000485	CcSEcCtD
Imiquimod—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000202	0.000484	CcSEcCtD
Imiquimod—Decreased appetite—Dexamethasone—multiple sclerosis	0.000202	0.000484	CcSEcCtD
Imiquimod—Decreased appetite—Betamethasone—multiple sclerosis	0.000202	0.000484	CcSEcCtD
Imiquimod—Nausea—Mitoxantrone—multiple sclerosis	0.000202	0.000483	CcSEcCtD
Imiquimod—Infection—Prednisone—multiple sclerosis	0.000201	0.000482	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000201	0.000481	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000201	0.000481	CcSEcCtD
Imiquimod—Back pain—Methotrexate—multiple sclerosis	0.000201	0.000481	CcSEcCtD
Imiquimod—Fatigue—Betamethasone—multiple sclerosis	0.000201	0.00048	CcSEcCtD
Imiquimod—Fatigue—Dexamethasone—multiple sclerosis	0.000201	0.00048	CcSEcCtD
Imiquimod—Shock—Prednisone—multiple sclerosis	0.0002	0.000477	CcSEcCtD
Imiquimod—Pain—Dexamethasone—multiple sclerosis	0.000199	0.000476	CcSEcCtD
Imiquimod—Pain—Betamethasone—multiple sclerosis	0.000199	0.000476	CcSEcCtD
Imiquimod—Nervous system disorder—Prednisone—multiple sclerosis	0.000199	0.000476	CcSEcCtD
Imiquimod—Tachycardia—Prednisone—multiple sclerosis	0.000198	0.000474	CcSEcCtD
Imiquimod—Skin disorder—Prednisone—multiple sclerosis	0.000197	0.000471	CcSEcCtD
Imiquimod—TLR8—Immune System—IFNG—multiple sclerosis	0.000196	0.000736	CbGpPWpGaD
Imiquimod—Hyperhidrosis—Prednisone—multiple sclerosis	0.000196	0.000469	CcSEcCtD
Imiquimod—TLR7—Immune System—ICAM1—multiple sclerosis	0.000196	0.000733	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—multiple sclerosis	0.000195	0.00073	CbGpPWpGaD
Imiquimod—Anorexia—Prednisone—multiple sclerosis	0.000193	0.000463	CcSEcCtD
Imiquimod—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000193	0.000461	CcSEcCtD
Imiquimod—Feeling abnormal—Betamethasone—multiple sclerosis	0.000192	0.000459	CcSEcCtD
Imiquimod—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000192	0.000459	CcSEcCtD
Imiquimod—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.00019	0.000456	CcSEcCtD
Imiquimod—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.00019	0.000456	CcSEcCtD
Imiquimod—TLR8—Immune System—CD4—multiple sclerosis	0.00019	0.000711	CbGpPWpGaD
Imiquimod—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000189	0.000709	CbGpPWpGaD
Imiquimod—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000189	0.000452	CcSEcCtD
Imiquimod—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000189	0.000451	CcSEcCtD
Imiquimod—TLR7—Immune System—CD80—multiple sclerosis	0.000188	0.000706	CbGpPWpGaD
Imiquimod—Malaise—Methotrexate—multiple sclerosis	0.000187	0.000448	CcSEcCtD
Imiquimod—Urticaria—Dexamethasone—multiple sclerosis	0.000185	0.000443	CcSEcCtD
Imiquimod—Urticaria—Betamethasone—multiple sclerosis	0.000185	0.000443	CcSEcCtD
Imiquimod—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000185	0.000442	CcSEcCtD
Imiquimod—Dizziness—Prednisolone—multiple sclerosis	0.000185	0.000442	CcSEcCtD
Imiquimod—Asthenia—Triamcinolone—multiple sclerosis	0.000184	0.000441	CcSEcCtD
Imiquimod—Body temperature increased—Dexamethasone—multiple sclerosis	0.000184	0.00044	CcSEcCtD
Imiquimod—Abdominal pain—Dexamethasone—multiple sclerosis	0.000184	0.00044	CcSEcCtD
Imiquimod—Abdominal pain—Betamethasone—multiple sclerosis	0.000184	0.00044	CcSEcCtD
Imiquimod—Body temperature increased—Betamethasone—multiple sclerosis	0.000184	0.00044	CcSEcCtD
Imiquimod—Asthenia—Methylprednisolone—multiple sclerosis	0.000184	0.00044	CcSEcCtD
Imiquimod—Insomnia—Prednisone—multiple sclerosis	0.000183	0.000439	CcSEcCtD
Imiquimod—Paraesthesia—Prednisone—multiple sclerosis	0.000182	0.000436	CcSEcCtD
Imiquimod—Pruritus—Triamcinolone—multiple sclerosis	0.000182	0.000434	CcSEcCtD
Imiquimod—Cough—Methotrexate—multiple sclerosis	0.000181	0.000434	CcSEcCtD
Imiquimod—Pruritus—Methylprednisolone—multiple sclerosis	0.000181	0.000434	CcSEcCtD
Imiquimod—Convulsion—Methotrexate—multiple sclerosis	0.00018	0.000431	CcSEcCtD
Imiquimod—Dyspepsia—Prednisone—multiple sclerosis	0.000179	0.000427	CcSEcCtD
Imiquimod—Chest pain—Methotrexate—multiple sclerosis	0.000177	0.000423	CcSEcCtD
Imiquimod—Arthralgia—Methotrexate—multiple sclerosis	0.000177	0.000423	CcSEcCtD
Imiquimod—Myalgia—Methotrexate—multiple sclerosis	0.000177	0.000423	CcSEcCtD
Imiquimod—Decreased appetite—Prednisone—multiple sclerosis	0.000176	0.000422	CcSEcCtD
Imiquimod—TLR8—Innate Immune System—IL6—multiple sclerosis	0.000176	0.00066	CbGpPWpGaD
Imiquimod—Rash—Prednisolone—multiple sclerosis	0.000176	0.000421	CcSEcCtD
Imiquimod—Dermatitis—Prednisolone—multiple sclerosis	0.000176	0.000421	CcSEcCtD
Imiquimod—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000176	0.00042	CcSEcCtD
Imiquimod—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000175	0.000419	CcSEcCtD
Imiquimod—TLR8—Immune System—IL1B—multiple sclerosis	0.000175	0.000656	CbGpPWpGaD
Imiquimod—Fatigue—Prednisone—multiple sclerosis	0.000175	0.000418	CcSEcCtD
Imiquimod—Headache—Prednisolone—multiple sclerosis	0.000175	0.000418	CcSEcCtD
Imiquimod—Discomfort—Methotrexate—multiple sclerosis	0.000175	0.000418	CcSEcCtD
Imiquimod—TLR8—Immune System—IL2—multiple sclerosis	0.000175	0.000654	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—MAPK1—multiple sclerosis	0.000174	0.000651	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—multiple sclerosis	0.000174	0.000651	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—multiple sclerosis	0.000173	0.000648	CbGpPWpGaD
Imiquimod—Dizziness—Triamcinolone—multiple sclerosis	0.00017	0.000406	CcSEcCtD
Imiquimod—Dizziness—Methylprednisolone—multiple sclerosis	0.000169	0.000405	CcSEcCtD
Imiquimod—Infection—Methotrexate—multiple sclerosis	0.000168	0.000403	CcSEcCtD
Imiquimod—Feeling abnormal—Prednisone—multiple sclerosis	0.000167	0.0004	CcSEcCtD
Imiquimod—Asthenia—Dexamethasone—multiple sclerosis	0.000167	0.0004	CcSEcCtD
Imiquimod—Asthenia—Betamethasone—multiple sclerosis	0.000167	0.0004	CcSEcCtD
Imiquimod—Nervous system disorder—Methotrexate—multiple sclerosis	0.000166	0.000398	CcSEcCtD
Imiquimod—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000166	0.000397	CcSEcCtD
Imiquimod—Nausea—Prednisolone—multiple sclerosis	0.000166	0.000397	CcSEcCtD
Imiquimod—Pruritus—Betamethasone—multiple sclerosis	0.000165	0.000394	CcSEcCtD
Imiquimod—Pruritus—Dexamethasone—multiple sclerosis	0.000165	0.000394	CcSEcCtD
Imiquimod—Skin disorder—Methotrexate—multiple sclerosis	0.000165	0.000394	CcSEcCtD
Imiquimod—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000164	0.000392	CcSEcCtD
Imiquimod—Vomiting—Triamcinolone—multiple sclerosis	0.000163	0.00039	CcSEcCtD
Imiquimod—Vomiting—Methylprednisolone—multiple sclerosis	0.000163	0.00039	CcSEcCtD
Imiquimod—Rash—Triamcinolone—multiple sclerosis	0.000162	0.000387	CcSEcCtD
Imiquimod—Dermatitis—Triamcinolone—multiple sclerosis	0.000162	0.000387	CcSEcCtD
Imiquimod—Anorexia—Methotrexate—multiple sclerosis	0.000162	0.000387	CcSEcCtD
Imiquimod—Rash—Methylprednisolone—multiple sclerosis	0.000161	0.000386	CcSEcCtD
Imiquimod—Dermatitis—Methylprednisolone—multiple sclerosis	0.000161	0.000386	CcSEcCtD
Imiquimod—Urticaria—Prednisone—multiple sclerosis	0.000161	0.000385	CcSEcCtD
Imiquimod—Headache—Triamcinolone—multiple sclerosis	0.000161	0.000385	CcSEcCtD
Imiquimod—Headache—Methylprednisolone—multiple sclerosis	0.00016	0.000384	CcSEcCtD
Imiquimod—Abdominal pain—Prednisone—multiple sclerosis	0.00016	0.000384	CcSEcCtD
Imiquimod—Body temperature increased—Prednisone—multiple sclerosis	0.00016	0.000384	CcSEcCtD
Imiquimod—Diarrhoea—Betamethasone—multiple sclerosis	0.000159	0.000381	CcSEcCtD
Imiquimod—Diarrhoea—Dexamethasone—multiple sclerosis	0.000159	0.000381	CcSEcCtD
Imiquimod—TLR7—Immune System—TYK2—multiple sclerosis	0.000159	0.000596	CbGpPWpGaD
Imiquimod—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000154	0.000369	CcSEcCtD
Imiquimod—Dizziness—Betamethasone—multiple sclerosis	0.000154	0.000368	CcSEcCtD
Imiquimod—Dizziness—Dexamethasone—multiple sclerosis	0.000154	0.000368	CcSEcCtD
Imiquimod—CYP1A2—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000153	0.000575	CbGpPWpGaD
Imiquimod—Insomnia—Methotrexate—multiple sclerosis	0.000153	0.000367	CcSEcCtD
Imiquimod—Nausea—Triamcinolone—multiple sclerosis	0.000152	0.000365	CcSEcCtD
Imiquimod—Paraesthesia—Methotrexate—multiple sclerosis	0.000152	0.000364	CcSEcCtD
Imiquimod—Nausea—Methylprednisolone—multiple sclerosis	0.000152	0.000364	CcSEcCtD
Imiquimod—Dyspnoea—Methotrexate—multiple sclerosis	0.000151	0.000362	CcSEcCtD
Imiquimod—Somnolence—Methotrexate—multiple sclerosis	0.000151	0.000361	CcSEcCtD
Imiquimod—Hypersensitivity—Prednisone—multiple sclerosis	0.000149	0.000358	CcSEcCtD
Imiquimod—Dyspepsia—Methotrexate—multiple sclerosis	0.000149	0.000357	CcSEcCtD
Imiquimod—TLR7—Immune System—IFNG—multiple sclerosis	0.000149	0.000558	CbGpPWpGaD
Imiquimod—Vomiting—Betamethasone—multiple sclerosis	0.000148	0.000354	CcSEcCtD
Imiquimod—Vomiting—Dexamethasone—multiple sclerosis	0.000148	0.000354	CcSEcCtD
Imiquimod—Decreased appetite—Methotrexate—multiple sclerosis	0.000147	0.000353	CcSEcCtD
Imiquimod—TLR8—Immune System—STAT3—multiple sclerosis	0.000147	0.00055	CbGpPWpGaD
Imiquimod—Rash—Betamethasone—multiple sclerosis	0.000147	0.000351	CcSEcCtD
Imiquimod—Rash—Dexamethasone—multiple sclerosis	0.000147	0.000351	CcSEcCtD
Imiquimod—Dermatitis—Betamethasone—multiple sclerosis	0.000147	0.000351	CcSEcCtD
Imiquimod—Dermatitis—Dexamethasone—multiple sclerosis	0.000147	0.000351	CcSEcCtD
Imiquimod—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000146	0.00035	CcSEcCtD
Imiquimod—Fatigue—Methotrexate—multiple sclerosis	0.000146	0.00035	CcSEcCtD
Imiquimod—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	0.000146	0.000547	CbGpPWpGaD
Imiquimod—Headache—Betamethasone—multiple sclerosis	0.000146	0.000349	CcSEcCtD
Imiquimod—Headache—Dexamethasone—multiple sclerosis	0.000146	0.000349	CcSEcCtD
Imiquimod—Asthenia—Prednisone—multiple sclerosis	0.000146	0.000348	CcSEcCtD
Imiquimod—Pain—Methotrexate—multiple sclerosis	0.000145	0.000347	CcSEcCtD
Imiquimod—TLR7—Immune System—CD4—multiple sclerosis	0.000144	0.000539	CbGpPWpGaD
Imiquimod—Pruritus—Prednisone—multiple sclerosis	0.000143	0.000343	CcSEcCtD
Imiquimod—Feeling abnormal—Methotrexate—multiple sclerosis	0.00014	0.000334	CcSEcCtD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000139	0.000521	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000139	0.000521	CbGpPWpGaD
Imiquimod—Diarrhoea—Prednisone—multiple sclerosis	0.000139	0.000332	CcSEcCtD
Imiquimod—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000139	0.000332	CcSEcCtD
Imiquimod—Nausea—Dexamethasone—multiple sclerosis	0.000138	0.000331	CcSEcCtD
Imiquimod—Nausea—Betamethasone—multiple sclerosis	0.000138	0.000331	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000135	0.000507	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000135	0.000506	CbGpPWpGaD
Imiquimod—Urticaria—Methotrexate—multiple sclerosis	0.000135	0.000322	CcSEcCtD
Imiquimod—Dizziness—Prednisone—multiple sclerosis	0.000134	0.000321	CcSEcCtD
Imiquimod—Abdominal pain—Methotrexate—multiple sclerosis	0.000134	0.000321	CcSEcCtD
Imiquimod—Body temperature increased—Methotrexate—multiple sclerosis	0.000134	0.000321	CcSEcCtD
Imiquimod—TLR8—Immune System—MAPK1—multiple sclerosis	0.000133	0.0005	CbGpPWpGaD
Imiquimod—TLR7—Innate Immune System—IL6—multiple sclerosis	0.000133	0.0005	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL1B—multiple sclerosis	0.000133	0.000498	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000132	0.000496	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL2—multiple sclerosis	0.000132	0.000496	CbGpPWpGaD
Imiquimod—Vomiting—Prednisone—multiple sclerosis	0.000129	0.000309	CcSEcCtD
Imiquimod—Rash—Prednisone—multiple sclerosis	0.000128	0.000306	CcSEcCtD
Imiquimod—Dermatitis—Prednisone—multiple sclerosis	0.000128	0.000306	CcSEcCtD
Imiquimod—Headache—Prednisone—multiple sclerosis	0.000127	0.000304	CcSEcCtD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000126	0.000472	CbGpPWpGaD
Imiquimod—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000126	0.000472	CbGpPWpGaD
Imiquimod—Hypersensitivity—Methotrexate—multiple sclerosis	0.000125	0.000299	CcSEcCtD
Imiquimod—Asthenia—Methotrexate—multiple sclerosis	0.000122	0.000291	CcSEcCtD
Imiquimod—Nausea—Prednisone—multiple sclerosis	0.00012	0.000288	CcSEcCtD
Imiquimod—Pruritus—Methotrexate—multiple sclerosis	0.00012	0.000287	CcSEcCtD
Imiquimod—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	0.000118	0.000444	CbGpPWpGaD
Imiquimod—Diarrhoea—Methotrexate—multiple sclerosis	0.000116	0.000277	CcSEcCtD
Imiquimod—Dizziness—Methotrexate—multiple sclerosis	0.000112	0.000268	CcSEcCtD
Imiquimod—TLR7—Immune System—STAT3—multiple sclerosis	0.000111	0.000417	CbGpPWpGaD
Imiquimod—Vomiting—Methotrexate—multiple sclerosis	0.000108	0.000258	CcSEcCtD
Imiquimod—Rash—Methotrexate—multiple sclerosis	0.000107	0.000256	CcSEcCtD
Imiquimod—Dermatitis—Methotrexate—multiple sclerosis	0.000107	0.000255	CcSEcCtD
Imiquimod—Headache—Methotrexate—multiple sclerosis	0.000106	0.000254	CcSEcCtD
Imiquimod—TLR8—Immune System—IL6—multiple sclerosis	0.000103	0.000384	CbGpPWpGaD
Imiquimod—TLR7—Immune System—MAPK1—multiple sclerosis	0.000101	0.000379	CbGpPWpGaD
Imiquimod—Nausea—Methotrexate—multiple sclerosis	0.000101	0.000241	CcSEcCtD
Imiquimod—CYP1A2—Metabolism—SRM—multiple sclerosis	8.79e-05	0.000329	CbGpPWpGaD
Imiquimod—CYP1A2—Biological oxidations—POMC—multiple sclerosis	8.15e-05	0.000305	CbGpPWpGaD
Imiquimod—TLR7—Immune System—IL6—multiple sclerosis	7.77e-05	0.000291	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—SRM—multiple sclerosis	6.79e-05	0.000254	CbGpPWpGaD
Imiquimod—CYP3A4—Biological oxidations—POMC—multiple sclerosis	6.29e-05	0.000236	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	6.19e-05	0.000232	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	6.19e-05	0.000232	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.05e-05	0.000227	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—GPC5—multiple sclerosis	5.67e-05	0.000212	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	4.78e-05	0.000179	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	4.78e-05	0.000179	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—RRM1—multiple sclerosis	4.69e-05	0.000176	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—GPC5—multiple sclerosis	4.37e-05	0.000164	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.64e-05	0.000136	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—RRM1—multiple sclerosis	3.62e-05	0.000136	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.13e-05	0.000117	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.85e-05	0.000107	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—BCHE—multiple sclerosis	2.7e-05	0.000101	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—BCHE—multiple sclerosis	2.08e-05	7.8e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—APOE—multiple sclerosis	1.62e-05	6.08e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—POMC—multiple sclerosis	1.39e-05	5.22e-05	CbGpPWpGaD
Imiquimod—CYP1A2—Metabolism—ALB—multiple sclerosis	1.27e-05	4.76e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—APOE—multiple sclerosis	1.25e-05	4.69e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—POMC—multiple sclerosis	1.08e-05	4.03e-05	CbGpPWpGaD
Imiquimod—CYP3A4—Metabolism—ALB—multiple sclerosis	9.8e-06	3.67e-05	CbGpPWpGaD
